[1]
Diani Nur Pathona, “THE ROLE OF SODIUM–GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS IN REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS : A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES”, the int. j. of med. science and health, vol. 48, no. 5, pp. 135–230, Aug. 2026, doi: 10.70070/dver3926.